Significantly reduced incidence and improved survival from prostate cancer over 25 years

Background Prostate cancer (PCa) was the second most frequent cancer and the fifth leading cause of cancer death among men in 2020. The aim of this study was to analyze trends in the incidence, mortality and survival of PCa in Girona, Spain, over 25 years. Methods Population-based study of PCa colle...

Descripción completa

Detalles Bibliográficos
Autores: Serdà, Bernat-Carles, Sanvisens, Arantza, Fuentes Raspall, Rafael, Puigdemont, Montserrat, Farré Pueyo, Xavier, Vidal-Vila, Anna, Rispau-Pagès, Martí, Baltasar Bagué, Alícia, Marcos-Gragera, Rafael
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10256/27098
Acceso en línea:http://hdl.handle.net/10256/27098
Access Level:acceso abierto
Palabra clave:Pròstata -- Càncer
Prostate -- Cancer
id ES_c64ac9e8782e730647bbb3367ee46fbd
oai_identifier_str oai:recercat.cat:10256/27098
network_acronym_str ES
network_name_str España
repository_id_str
spelling Significantly reduced incidence and improved survival from prostate cancer over 25 yearsSerdà, Bernat-CarlesSanvisens, ArantzaFuentes Raspall, RafaelPuigdemont, MontserratFarré Pueyo, XavierVidal-Vila, AnnaRispau-Pagès, MartíBaltasar Bagué, AlíciaMarcos-Gragera, RafaelPròstata -- CàncerProstate -- CancerBackground Prostate cancer (PCa) was the second most frequent cancer and the fifth leading cause of cancer death among men in 2020. The aim of this study was to analyze trends in the incidence, mortality and survival of PCa in Girona, Spain, over 25 years. Methods Population-based study of PCa collected in the Girona Cancer Registry, 1994-2018. Age-adjusted incidence and mortality rates were calculated per 100,000 men-year. Joinpoint regression models were used for trends, calculating the annual percentage changes (APC). Observed and net survival were analyzed using Kaplan-Meier and Pohar-Perme estimations, respectively. Results A total of 9,846 cases of PCa were registered between 1994-2018. The age-adjusted incidence and mortality rates were 154.7 (95%CI: 151.7 157.8) and 38.9 (95%CI: 37.3 -40.6), respectively. An increased incidence of 6.2% was observed from 1994 to 2003 (95%CI: 4.4 -8.1), and a decrease of -2.7% (95%CI: -3.5 -;-1.9) between 2003 and 2018. Mortality APC was -2.6% (95%CI: -3.3 --2.0). Five-year observed and net survival were 72.8% (95%CI: 71.8 - 73.7) and 87.2% (95%CI: 85.9 - 88.4), respectively. Five-year net survival increased over time from 72.9% (1994-1998) to 91.3% (2014-2018). Conclusions The analyses show a clear reduction in PCa incidence rates from 2003 on, along with an increase in overall survival when comparing the earlier period with more recent yearsBioMed Central2023info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionpeer-reviewedapplication/pdfhttp://hdl.handle.net/10256/27098http://hdl.handle.net/10256/27098BMC Public Health, 2023, vol. 23, art.núm. 2552Articles publicats (D-I)Serdà, Bernat-Carles Sanvisens, Arantza Fuentes Raspall, Rafael Puigdemont, Montserrat Farré Pueyo, Xavier Vidal-Vila, Anna Rispau-Pagès, Martí Baltasar Bagué, Alícia Marcos-Gragera, Rafael 2023 Significantly reduced incidence and improved survival from prostate cancer over 25 years BMC Public Health 23 art.núm. 2552reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)Inglésinfo:eu-repo/semantics/altIdentifier/doi/10.1186/s12889-023-17440-7info:eu-repo/semantics/altIdentifier/eissn/1471-2458Attribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:10256/270982026-05-29T05:05:01Z
dc.title.none.fl_str_mv Significantly reduced incidence and improved survival from prostate cancer over 25 years
title Significantly reduced incidence and improved survival from prostate cancer over 25 years
spellingShingle Significantly reduced incidence and improved survival from prostate cancer over 25 years
Serdà, Bernat-Carles
Pròstata -- Càncer
Prostate -- Cancer
title_short Significantly reduced incidence and improved survival from prostate cancer over 25 years
title_full Significantly reduced incidence and improved survival from prostate cancer over 25 years
title_fullStr Significantly reduced incidence and improved survival from prostate cancer over 25 years
title_full_unstemmed Significantly reduced incidence and improved survival from prostate cancer over 25 years
title_sort Significantly reduced incidence and improved survival from prostate cancer over 25 years
dc.creator.none.fl_str_mv Serdà, Bernat-Carles
Sanvisens, Arantza
Fuentes Raspall, Rafael
Puigdemont, Montserrat
Farré Pueyo, Xavier
Vidal-Vila, Anna
Rispau-Pagès, Martí
Baltasar Bagué, Alícia
Marcos-Gragera, Rafael
author Serdà, Bernat-Carles
author_facet Serdà, Bernat-Carles
Sanvisens, Arantza
Fuentes Raspall, Rafael
Puigdemont, Montserrat
Farré Pueyo, Xavier
Vidal-Vila, Anna
Rispau-Pagès, Martí
Baltasar Bagué, Alícia
Marcos-Gragera, Rafael
author_role author
author2 Sanvisens, Arantza
Fuentes Raspall, Rafael
Puigdemont, Montserrat
Farré Pueyo, Xavier
Vidal-Vila, Anna
Rispau-Pagès, Martí
Baltasar Bagué, Alícia
Marcos-Gragera, Rafael
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Pròstata -- Càncer
Prostate -- Cancer
topic Pròstata -- Càncer
Prostate -- Cancer
description Background Prostate cancer (PCa) was the second most frequent cancer and the fifth leading cause of cancer death among men in 2020. The aim of this study was to analyze trends in the incidence, mortality and survival of PCa in Girona, Spain, over 25 years. Methods Population-based study of PCa collected in the Girona Cancer Registry, 1994-2018. Age-adjusted incidence and mortality rates were calculated per 100,000 men-year. Joinpoint regression models were used for trends, calculating the annual percentage changes (APC). Observed and net survival were analyzed using Kaplan-Meier and Pohar-Perme estimations, respectively. Results A total of 9,846 cases of PCa were registered between 1994-2018. The age-adjusted incidence and mortality rates were 154.7 (95%CI: 151.7 157.8) and 38.9 (95%CI: 37.3 -40.6), respectively. An increased incidence of 6.2% was observed from 1994 to 2003 (95%CI: 4.4 -8.1), and a decrease of -2.7% (95%CI: -3.5 -;-1.9) between 2003 and 2018. Mortality APC was -2.6% (95%CI: -3.3 --2.0). Five-year observed and net survival were 72.8% (95%CI: 71.8 - 73.7) and 87.2% (95%CI: 85.9 - 88.4), respectively. Five-year net survival increased over time from 72.9% (1994-1998) to 91.3% (2014-2018). Conclusions The analyses show a clear reduction in PCa incidence rates from 2003 on, along with an increase in overall survival when comparing the earlier period with more recent years
publishDate 2023
dc.date.none.fl_str_mv 2023
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
peer-reviewed
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10256/27098
http://hdl.handle.net/10256/27098
url http://hdl.handle.net/10256/27098
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1186/s12889-023-17440-7
info:eu-repo/semantics/altIdentifier/eissn/1471-2458
dc.rights.none.fl_str_mv Attribution 4.0 International (CC BY 4.0)
https://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution 4.0 International (CC BY 4.0)
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv BMC Public Health, 2023, vol. 23, art.núm. 2552
Articles publicats (D-I)
Serdà, Bernat-Carles Sanvisens, Arantza Fuentes Raspall, Rafael Puigdemont, Montserrat Farré Pueyo, Xavier Vidal-Vila, Anna Rispau-Pagès, Martí Baltasar Bagué, Alícia Marcos-Gragera, Rafael 2023 Significantly reduced incidence and improved survival from prostate cancer over 25 years BMC Public Health 23 art.núm. 2552
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419061103820800
score 15,198674

Similares en LA Referencia